Integrative Clinical, Radiological, and Molecular Analysis for Predicting Remission and Recurrence of Cushing Disease.

Paloma Moreno-MorenoAlejandro Ibáñez-CostaEva Venegas-MorenoAntonio C Fuentes-FayosMaría R Alhambra-ExpósitoCarmen Fajardo-MontañanaAraceli García-MartínezElena DiosMari C Vázquez-BorregoPablo Remón-RuizRosa CámaraCristina LamasJosé Carlos Padillo-CuencaJuan SoliveraDavid A CanoManuel D GaheteAura Dulcinea Herrera-MartínezAntonio PicóAlfonso Soto-MorenoMaría Ángeles Gálvez-MorenoJusto P. Castaño Raul Miguel Luque

Published in: The Journal of clinical endocrinology and metabolism (2022)

This study demonstrates that the combination of a set of clinical and molecular biomarkers in ACTHomas is able to accurately predict the clinical evolution and remission of patients. Consequently, the postsurgery molecular profile represents a valuable tool for clinical evaluation and follow-up of patients with ACTHomas.

Keyphrases

clinical evaluation
end stage renal disease
ejection fraction
newly diagnosed
disease activity
prognostic factors
ulcerative colitis